| Market revenue in 2024 | USD 157.2 million |
| Market revenue in 2030 | USD 246.0 million |
| Growth rate | 7.4% (CAGR from 2025 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Reagents |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents |
Being a high-income country, the UAE government aims to provide universal access to updated and advanced healthcare services by 2021. Due to its vast financial resources and adequate government funding, the molecular diagnostics market in UAE is likely to progress steadily.
In May 2024, a groundbreaking laboratory, OncoHelix-CoLab, was launched at a premier quaternary care private hospital in Abu Dhabi, UAE. This state-of-the-art facility specializes in advanced molecular diagnostics, including cancer genomic profiling, transplant diagnostics, and immunology testing.
By utilizing cuttingedge technologies such as next-generation sequencing (NGS), droplet digital PCR, and multi-color flow cytometry, OncoHelix-CoLab provides a range of sophisticated tests that were previously unavailable locally.
Publish Date: Jan 08, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 71.31% in 2024.
Horizon Databook has segmented the Uae molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
Being a high-income country, the UAE government aims to provide universal access to updated and advanced healthcare services by 2021. Due to its vast financial resources and adequate government funding, the molecular diagnostics market in UAE is likely to progress steadily.
In May 2024, a groundbreaking laboratory, OncoHelix-CoLab, was launched at a premier quaternary care private hospital in Abu Dhabi, UAE. This state-of-the-art facility specializes in advanced molecular diagnostics, including cancer genomic profiling, transplant diagnostics, and immunology testing.
By utilizing cuttingedge technologies such as next-generation sequencing (NGS), droplet digital PCR, and multi-color flow cytometry, OncoHelix-CoLab provides a range of sophisticated tests that were previously unavailable locally.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Molecular Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
